When it comes to prescribing CGM for your Medicare patients, we know cost is on your mind. Dexcom G7 is covered for 100% of patients on insulin or with a history of severe hypoglycemia.*,†,¹ Help your patients take better control with an affordable option. Check their eligibility today. * Use ICD-10-2025 code E10, Z79.4 for type 1 diabetes with insulin or E11, Z79.4 for type 2 diabetes with insulin. Under Medicare’s DME fee schedule, reimbursement and coinsurance for CGMs using CPT® codes A4239

Say hello to Dexcom G7 15 Day—Dexcom’s longest-lasting* and most accurate CGM system. It delivers real-time glucose readings for up to 15.5 days†, with no fingersticks§ or scanning required. See your glucose trends right on your phone‡ and make smarter diabetes management decisions. Learn more here: https://www.dexcom.com/g7-cgm-system *Longest-lasting among Dexcom CGM systems. †Sensor life may vary. §If your glucose alerts and readings from Dexcom CGM do not match symptoms or expectations, use

One small wearable. And zero fingersticks*. Learn why Medicare patients are using the Dexcom G6 Continuous Glucose Monitoring (CGM) System to manage diabetes. *If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. *For a list of compatible devices, visit dexcom.com/compatibility. Dexcom is a registered trademark of Dexcom, Inc. in the U.S., and may be registered in other countries. ©2020 Dexcom, Inc.